Nektar Therapeutics stock took a hit Thursday despite test results that suggested its drug has long-term benefits for alopecia patients. The post Nektar Posted Promising Alopecia Results. Here's Why It Took A 22% Beating. appeared first on Investor's Business Daily .

General T2NKTR

Investing.com 7d ago

Nektar presents long-term data on alopecia areata drug candidate

General T3NKTR

Investing.com 13d ago

Nektar Therapeutics stock rises on $90M jury verdict vs Lilly

General T3LLY NKTR

Seeking Alpha 13d ago

Nektar gains 5% as jury awards $90M plus interest in Lilly trial

General T2LLY NKTR

Seeking Alpha 16d ago

Nektar Therapeutics drops as jury deliberates in Eli Lilly patent dispute over Rezpeg

General T2LLY NKTR

Also mentioned with NKTR

30d

LLY3
RJF1

Headlines that tag both tickers

NKTR news alerts

Get an alert by email or push when a new headline mentions NKTR.

More news

News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.